Price
$2.08-24.82%Social Signal Score
Analyst Ratings
3 analystsRevenue
$8.84MAnalyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- Zaki Rakib
- Sector
- Industrials
- Industry
- Agricultural - Commodities/Milling
- Employees
- 89
- Beta
- 1.38
- Country
- CA
- Piotroski score
- 2 / 9 (Weak)
- Altman Z-score
- -2.44
Financials
Revenue
$8.84M+20940.5%Net Income
$-3.71MEBITDA
$-2.02MFree Cash Flow
$-3.33MEPS (diluted)
$-0.16Shares Outstanding (diluted)
22.67M+5348.3%Operating Expenses
$7.59MCash & Debt
$16.22MRevenue by Segment (annual)
$67.14MQuote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $34.51M | $-11.13M | $-0.60 |
| 2024 | $25.19M | $-12.91M | $-0.80 |
| 2023 | $12.67M | $-12.56M | $-0.93 |
| 2022 | $5.50M | $-11.24M | $-0.70 |
| 2021 | $2.10M | $-9.83M | $-0.70 |
| 2020 | $396.0K | $-6.58M | $-0.70 |
| 2019 | $218.0K | $-5.31M | $-1.75 |
| 2018 | $0.00 | $0.00 | $-2.34 |
| 2017 | $0.00 | $-5.0K | $-0.21 |
| 2016 | $0.00 | $-103.4K | $-0.27 |
| 2015 | $0.00 | $-123.7K | $-0.31 |
| 2014 | $0.00 | $0.00 | $-0.72 |
| 2013 | $0.00 | $0.00 | $-1.17 |
Valuation
BHSThas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.
Signal Score (90d)
30-79.07%Social Signal Score
Mentions (11)
- Newsnewsfilecorp.com·7d ago·Negative
…ciences Announces Share Repurchase Program Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - September 29, 2026) - BioHarvest Sciences Inc. (NASDAQ: BHST) (TASE: BHST) (FSE: 8MV0) ("BioHarvest" or the "Company"), a Botanical Synthesis company developing and manufacturing proprietary plant-based compositions for customers, partners and its own portfolio, announced today that its Board of Directors has authorized a share repurchase program, structured in accordance with Canadian p…
View source ↗ - Newsnewsfilecorp.com·21d ago·Neutral
…itions to differentiated consumer products Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - September 15, 2026) - BioHarvest Sciences Inc. (NASDAQ: BHST) (TASE: BHST) (FSE: 8MV0), a Botanical Synthesis company developing and manufacturing proprietary plant-based compositions for customers and its own portfolio, today announced the launch of single-dose VINIA® Daily Chews. The new delivery format is designed to expand the addressable market for VINIA and to further demonstrate B…
View source ↗ - Newsproactiveinvestors.com·32d ago·Neutral
Fiinu shares jump over 6% as Conister Bank platform enters production Fiinu (AIM: BANK), the UK fintech group, rose over 6% to 4p on Friday after its Plugin Overdraft platform moved into production ahead of a planned year-end...
View source ↗ - Newsproactiveinvestors.com·33d ago·Neutral
BioHarvest Sciences plans Tel Aviv Stock Exchange dual listing BioHarvest Sciences Inc (NASDAQ:BHST, FRA:8MV0) plans to pursue a dual listing of its ordinary shares on the Tel Aviv Stock Exchange (TASE), with trading expected to begin on September 8, 2026. The company, which is listed on the Nasdaq Capital Market, expects the TASE listing to provide investors in Israel with access to its shares.
View source ↗ - Newsnewsfilecorp.com·33d ago·Neutral
…sting on the Tel Aviv Stock Exchange (TASE) Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - September 3, 2026) - BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0), a leader in Botanical Synthesis technology and sustainable plant-based molecule development today announced its intention to offer its ordinary shares on the Tel Aviv Stock Exchange (TASE) and to become dual-listed for trade on both the Nasdaq and TASE markets. BioHarvest expects its shares to begin trading on the…
View source ↗ - Newsseekingalpha.com·55d ago·Positive
BioHarvest Sciences Inc. (BHST) Q2 2026 Earnings Call Transcript BioHarvest Sciences Inc. (BHST) Q2 2026 Earnings Call Transcript
View source ↗ - Newsmarketbeat.com·56d ago·Neutral
BioHarvest Sciences Q2 Earnings Call Highlights BioHarvest Sciences NASDAQ: BHST reported second-quarter 2026 revenue of $8.8 million, up 3.8% from $8.5 million a year earlier, while highlighting its first manufacturing and supply agreement within its contract development and manufacturing organization, or CDMO, business.
View source ↗ - Newsproactiveinvestors.com·56d ago·Neutral
BioHarvest posts higher Q2 revenue, secures manufacturing deal for premium fragrance compound BioHarvest Sciences Inc (NASDAQ:BHST, FRA:8MV0) reported higher second-quarter revenue as the plant-based molecule developer shifted spending toward manufacturing capacity. Revenue for the quarter was $8.8 million, up 3.8% from a year earlier.
View source ↗ - Newszacks.com·56d ago·Negative
BioHarvest Sciences Inc. (BHST) Reports Q2 Loss, Lags Revenue Estimates BioHarvest Sciences Inc. (BHST) came out with a quarterly loss of $0.17 per share versus the Zacks Consensus Estimate of a loss of $0.13. This compares to a loss of $0.15 per share a year ago.
View source ↗ - Newsnewsfilecorp.com·56d ago·Negative
BioHarvest Reports Second Quarter 2026 Financial Results and Provides Business Update Secured first ever CDMO Manufacturing Agreement supporting planned 20-ton commercial production program over two years for rare botanical fragrance, that BioHarvest expects to drive profitable growth trajectory for CDMO business Reports $8.8 million in Q2 revenue, up 3.8% from Q2 2025 Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - August 11, 2026) - BioHarvest Sciences Inc (NASDAQ: BHST) (FS
View source ↗ - Newsnewsfilecorp.com·56d ago·Negative
BioHarvest Secures 20-Ton Manufacturing and Supply Agreement for Rare Botanical Luxury Fragrance Exclusive agreement through 2027 and 2028 is estimated to generate $20-$30 million in revenue Positions BioHarvest in sustainable rare luxury fragrance manufacturing BioHarvest to target additional collaborations in the high-margin rare fragrance space Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - August 11, 2026) - BioHarvest Sciences Inc (NASDAQ: BHST) (FSE: 8MV0), a leader in
View source ↗
Earnings
Thu, Nov 12(in 5 weeks)
Consensus estimate $-0.16 per share
Typical surprise +0.0% (median, so one quarter with a near-zero estimate can't distort it)
- Tue, Aug 11$-0.17 vs $-0.13miss
- Thu, May 14$-0.11 vs $-0.13beat
- Tue, Mar 31$-0.10 vs $-0.10beat
- Thu, Nov 13$-0.14 vs $-0.14beat
- Mon, Aug 11$-0.24 vs $-0.11miss
- Thu, May 15$-0.13 vs $-0.15beat
Estimates and results for BHST via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Congress trades
No disclosed congressional trades in BHST.
Self-reported filings, amounts as brackets. Via Senate/House disclosures.